Corcept Therapeutics (CORT) PT Raised to $42 at Truist Securities
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $114.47 +3.58%
Rating Summary:
7 Buy, 9 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
7 Buy, 9 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Truist Securities analyst Joon Lee raised the price target on Corcept Therapeutics (NASDAQ: CORT) to $42.00 (from $36.00) while maintaining a Buy rating.
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Apollo Hospitals (APLH:IN) PT Raised to INR8,500 at ICICI Securities
- Lithium Ionic Corp (LTH:CN) PT Lowered to Cdn$2.50 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
